1. Home
  2. EXPO vs CNTA Comparison

EXPO vs CNTA Comparison

Compare EXPO & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$66.24

Market Cap

3.4B

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

SELL

Current Price

$39.43

Market Cap

6.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
EXPO
CNTA
Founded
1967
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
6.1B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
EXPO
CNTA
Price
$66.24
$39.43
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$88.00
$43.17
AVG Volume (30 Days)
389.9K
3.0M
Earning Date
04-30-2026
05-13-2026
Dividend Yield
1.87%
N/A
EPS Growth
N/A
29.13
EPS
2.07
N/A
Revenue
$582,014,000.00
$15,000,000.00
Revenue This Year
$12.75
N/A
Revenue Next Year
$8.50
N/A
P/E Ratio
$32.00
N/A
Revenue Growth
4.21
N/A
52 Week Low
$63.25
$10.95
52 Week High
$81.95
$40.26

Technical Indicators

Market Signals
Indicator
EXPO
CNTA
Relative Strength Index (RSI) 47.65 73.10
Support Level $64.39 $39.16
Resistance Level $73.62 $40.26
Average True Range (ATR) 1.97 0.19
MACD 0.01 -0.48
Stochastic Oscillator 39.69 59.18

Price Performance

Historical Comparison
EXPO
CNTA

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.

Share on Social Networks: